These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2293211)

  • 1. Theophylline-controlled release preparations and fatty food: an in vitro study using the rotating dialysis cell method.
    el-Arini SK; Shiu GK; Skelly JP
    Pharm Res; 1990 Nov; 7(11):1134-40. PubMed ID: 2293211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur Sprinkle.
    Karim A; Burns T; Wearley L; Streicher J; Palmer M
    Clin Pharmacol Ther; 1985 Jul; 38(1):77-83. PubMed ID: 4006379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method of dissolution in vitro, the "Bio-Dis" apparatus: comparison with the rotating bottle method and in vitro: in vivo correlations.
    Esbelin B; Beyssac E; Aiache JM; Shiu GK; Skelly JP
    J Pharm Sci; 1991 Oct; 80(10):991-4. PubMed ID: 1784010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
    Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release and absorption characteristics of novel theophylline sustained-release formulations: in vitro-in vivo correlation.
    Hussein Z; Friedman M
    Pharm Res; 1990 Nov; 7(11):1167-71. PubMed ID: 2293217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative evaluation using in vitro dissolution tests of various sustained release theophylline preparations].
    Kissné CE
    Acta Pharm Hung; 1990 Nov; 60(5-6):191-6. PubMed ID: 2087990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro conditions for the study of the in vivo performance of sustained-release theophylline matrix tablets administered in fasted conditions and with a high-fat diet.
    Andonaegui MT; Barría JL; Thielemann AM; Seitz C; Gai MN
    Drug Dev Ind Pharm; 1999 Nov; 25(11):1199-203. PubMed ID: 10596358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
    Vashi VI; Meyer MC
    J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the pharmacodynamics and pharmacokinetics of theophylline.
    Hendeles L; Massanari M; Weinberger M
    Chest; 1985 Aug; 88(2 Suppl):103S-111S. PubMed ID: 3893922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms.
    el-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1985 Feb; 74(2):161-4. PubMed ID: 3989685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food interactions with sustained-release theophylline preparations. A review.
    Jonkman JH
    Clin Pharmacokinet; 1989 Mar; 16(3):162-79. PubMed ID: 2656048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of food on the absorption of theophylline in children.
    Pedersen S
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):704-9. PubMed ID: 3771960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of dissolution profiles of theophylline extended-release dosage forms.
    Wolny D; Gruchlik A; Chodurek E; Szara M; Dzierzewicz Z
    Acta Pol Pharm; 2012; 69(6):1384-6. PubMed ID: 23285707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apparent inconsistent theophylline absorption from sustained release capsules.
    Uden DL; Schaber DE; Wyatt RA
    Clin Pediatr (Phila); 1987 Jun; 26(6):285-7. PubMed ID: 3581636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of once-daily Uniphyl tablets compared with twice-daily Theo-Dur tablets in elderly patients with chronic airflow obstruction.
    Rivington RN; Calcutt L; Hodder RV; Stewart JH; Aitken TL
    Am J Med; 1988 Jul; 85(1B):48-53. PubMed ID: 3041826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Per-oral controlled release dosage form of theophylline using soybean protein.
    Machida Y; Tokumura T; Nagai T
    Drug Des Deliv; 1987 Feb; 1(3):187-92. PubMed ID: 3509332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of sustained release theophylline in low and high multidose regimens.
    Koëter GH; Jonkman JH; de Vries K; Schoenmaker R; Greving JE; de Zeeuw RA
    Br J Clin Pharmacol; 1981 Nov; 12(5):647-51. PubMed ID: 7332728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.